Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Blood|March 5, 2015
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticatorSimon Husby, Ulrik Ralfkiaer, Christian Garde, et al.
British Journal of Haematology|May 30, 2012
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occurChristian H Geisler, Arne Kolstad, Anna Laurell, et al.
Blood Neoplasia|August 14, 2025
Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based studyTrine Trab, Iman Chanchiri, Ahmed Ludvigsen Al-Mashhadi, et al.
Lancet (London, England)|December 18, 2015
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 studyMartin Dreyling, Wojciech Jurczak, Mats Jerkeman, et al.
Hemasphere|December 28, 2020
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3Christian Winther Eskelund, Kostas Dimopoulos, Arne Kolstad, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 2024
The National Swedish Lymphoma Register - a systematic validation of data qualityKarin Ekström Smedby, Sandra Eloranta, Tove Wästerlid, et al.
Blood|July 16, 2008
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma GroupChristian H Geisler, Arne Kolstad, Anna Laurell, et al.
Blood Advances|May 8, 2020
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxisSirpa Leppä, Judit Jørgensen, Anne Tierens, et al.
Clinical and Translational Medicine|December 6, 2022
The dual role of CD70 in B-cell lymphomagenesisMan Nie, Weicheng Ren, Xiaofei Ye, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2017
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 YearsArne Kolstad, Lone Bredo Pedersen, Christian W Eskelund, et al.
Pageof 17